psoriasis

This story originally ran on Oct. 18
French biotech company Hybrigenics this week reported €1.85 million ($2.52 million) in first-half revenues from its proteomics services business, up eight percent from €1.71 million in the first half of 2010.

The $399 PsoriasisDx Genetic Test is a sequencing-based assay that detects the presence of MICA-A9, an immune-response gene variant present in approximately 60 percent of patients with psoriatic arthritis.

The company also noted in a filing with the US Securities and Exchange Commission that it continues to seek out industry partnerships after having failed to forge a deal in 2008 as previously anticipated.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.